BRIEF published on 04/27/2026 at 18:05, 5 days 18 hours ago ABIVAX: Composition of share capital and voting rights Euronext Paris Share Capital Voting Rights Abivax Number Of Shares
BRIEF published on 04/22/2026 at 22:10, 10 days 14 hours ago Abivax unveils key data on obefazimod at Digestive Disease Week Abivax Obefazimod Ulcerative Colitis Clinical Trials Digestive Disease Week
BRIEF published on 04/22/2026 at 22:10, 10 days 14 hours ago Abivax to Present Data on Obefazimod at Digestive Disease Week® Abivax Obefazimod Ulcerative Colitis Phase 3 Clinical Trials DDW 2026
PRESS RELEASE published on 04/22/2026 at 22:05, 10 days 14 hours ago Abivax to Present Data on Obefazimod at Digestive Disease Week® Abivax to present data on Obefazimod at Digestive Disease Week, showcasing efficacy, safety, and patient outcomes from Phase 3 ABTECT program and preclinical anti-fibrotic models Abivax Obefazimod Clinical Trials Digestive Disease Week Inflammatory Bowel Disease
BRIEF published on 04/20/2026 at 22:10, 12 days 14 hours ago Abivax: Annual General Meeting scheduled for May 11, 2026 Biotechnology Abivax Obefazimod General Assembly Preparatory Documents
BRIEF published on 04/20/2026 at 22:10, 12 days 14 hours ago Abivax Prepares for General Meeting with Document Release Biotechnology Abivax Ulcerative Colitis General Meeting Preparatory Documents
PRESS RELEASE published on 04/20/2026 at 22:05, 12 days 14 hours ago Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents Abivax informs shareholders about the Annual Ordinary and Extraordinary General Meeting on May 11, 2026, in Paris, providing access to preparatory documents Shareholders Abivax General Meeting Clinical-stage Biotechnology Preparatory Documents
BRIEF published on 04/17/2026 at 15:48, 15 days 20 hours ago JP Morgan Chase & Co. crosses the 5% threshold in ABIVAX Voting Rights Abivax Threshold Crossing JP Morgan Indirect Ownership
BRIEF published on 04/17/2026 at 10:42, 16 days 1 hour ago JP Morgan Chase & Co. reduces its stake in ABIVAX Euronext Paris Voting Rights Abivax Threshold Crossing JP Morgan
BRIEF published on 04/08/2026 at 12:17, 25 days ago Abivax presents the results of the ABTECT trial Abivax Obefazimod Ulcerative Colitis Clinical Trial Tolérance
Published on 05/02/2026 at 21:00, 15 hours 22 minutes ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 10 hours ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 11 hours ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 12 hours ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 12 hours ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/03/2026 at 04:45, 7 hours 37 minutes ago GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 20 hours 47 minutes ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 16 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/30/2026 at 20:00, 2 days 16 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 2 days 17 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 2 days 17 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 2 days 18 hours ago Minutes of the Combined General Meeting held on April 30, 2026
